E-posters - Broadly neutralizing antibodies
Broadly neutralizing antibodies
•
EP2
•
>
•
E-posters - Broadly neutralizing antibodies
•
ePoster
Broadly neutralizing antibodies
•
1175
•
35O22 and VRC44 Define a New Highly Glycan-Dependent Multidonor Class of HIV-1 gp120:gp41 Interface-Directed bnAbs
>
E.
Evan
CALE
•
1227
•
Precursor Frequencies of naïve B cells targeting HIV candidate immunogens
>
M.
Madhu
PRABHAKARAN
•
1263
•
Low dose administration of unmodified 10E8v4, but not FcγR/complement dual enhanced or dual ablated 10E8v4 variants, decreases viremia in SHIV challenged macaques
>
D.
David
SPENCER
•
1273
•
Functional convergence of clonally related but genetically distinct bNAbs that target the V3-glycan epitope
>
D.
Dale
KITCHIN
•
1340
•
Enhanced Protection at the Site of Challenge of Rhesus Macaques That Receive PGT121 One Week Prior to Intravaginal Challenge With SHIV-SF162P3.
>
J.
Jeffrey
SCHNEIDER
•
1369
•
Functional barriers in the elicitation of broadly neutralizing antibodies against the glycan-V3 site of Env by vaccination
>
M.
Mihai
AZOITEI
•
1412
•
The near-pan-neutralizing, plasma deconvoluted antibody N49P6 mimics CD4 in its quaternary interactions with the HIV-1 envelope trimer
>
W.
William
TOLBERT
•
1431
•
Improved potency, breadth, and pharmacokinetics of VRC01-class antibodies for HIV-1 prevention and treatment
>
Y.
Young Do
KWON
•
1444
•
A lineage of exceptionally potent and broad BnAbs with ultralong CDRH3 from vaccinated cows focus low-mutation rate from germline into a globular knob contacting the CD4bs
>
N.
Natalia
SALAZAR QUIROZ
•
417
•
Structure of a CD4 binding site directed antibody in a donor with broadly neutralizing antibodies
>
T.
Thandeka
MOYO
•
480
•
Next Generation Variants of Super Potent CAP256-VRC26.25 Antibody with Near-Pan HIV-1 Neutralization Breadth
>
B.
Baoshan
ZHANG
•
532
•
Antibody-Antigen Distance of Broadly Neutralizing HIV-1 Antibodies Correlates with Glycan-Shield Coverage of HIV-1 Envelope Trimer
>
M.
Myungjin
LEE
•
563
•
Variation in neutralization susceptibility of HIV-1 Indian Subtype C to potent and broadly neutralizing monoclonal antibodies (bnAbs) having distinct epitope specificities
>
N.
Nitin
HINGANKAR
•
579
•
Antibody genetic diversity with large structural variation in a South African population
>
A.
Alaine
MARSDEN
•
660
•
Founder Env-specific IgM B cell responses during acute HIV-1 infection associate with the development of broadly neutralizing antibodies
>
S.
Samantha
TOWNSLEY
•
864
•
IgG3 HIV broadly neutralizing antibodies show improved neutralization potency and phagocytosis compared to IgG1 variants
>
S.
Simone
RICHARDSON
•
884
•
Defining the mechanism for varied neutralization potency of HIV neutralizing antibodies with identical variable regions but differing isotype
>
Z.
Zanele
MAKHADO
|